Overall Technical outlook

Price Summary

Glenmark Pharmaceuticals Limited's stock began trading at 2220.0 on 2025-07-16, soared to 2247.7, dipped to 2196.1, and finished the day -0.68% lower at 2204.8, with 1494725 shares exchanged.
Over the past year, the stock's highest price was 2226.1, and its lowest was 1278.95.
Analysts' predictions indicate that GLENMARK's future price will be between 1300.0 and 2011.0, with a mean price expectation of approximately 1678.4166.

Technicals


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
GLENMARK aroon 53f8e3
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for GLENMARK, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
GLENMARK bbands 53f8e3
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, establishing a key support level that could help uphold the market's upward trajectory. This persistent bullish outlook suggests that the market may continue to rise, with the support providing a foundation for further gains.
GLENMARK psar 53f8e3
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The stochastic indicator for GLENMARK shows a bullish signal, with the K-line positioned above the D-line and also above the 80 mark. This suggests strong upward momentum, indicating that the market may continue to trend higher. Traders might view this as a sign of continued strength and potential buying opportunities.
GLENMARK stoch 53f8e3
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages suggests a bearish trend, but the wavering slopes of the 20 and 50 SMAs hint at a potential shift. This weakening of momentum could indicate that the bearish trend is running out of steam, possibly leading to a bullish reversal in the near future. Investors should be aware of the possibility of a market turnaround as the current downtrend weakens for Glenmark Pharmaceuticals Limited.
GLENMARK trippleSMA 53f8e3
Tripple SMA chart for Glenmark Pharmaceuticals Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.